
Equillium, Inc.
EQHealthcare|Biotechnology|US
$1.51
+0.18 (+13.53%)
DCF Value
$0.32
Tangible Book / Share
$0.50
Cash / Share
$0.51
Next Earnings Report
Nov 12, 2026
EPS est. -$0.05
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Apr 7, 2026 (S-3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
Oct 26, 2026 · GlobeNewsWire
Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
Oct 6, 2026 · GlobeNewsWire
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
Oct 5, 2026 · GlobeNewsWire
Equillium Announces Poster Presentations at the 7th International AHR Conference
Sep 29, 2026 · GlobeNewsWire
Equillium to Participate in Stifel's 2026 Virtual Immunology and Inflammation Forum
Sep 16, 2026 · GlobeNewsWire
Equillium to Participate in Upcoming Investor Conferences
Sep 2, 2026 · GlobeNewsWire
Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Aug 13, 2026 · GlobeNewsWire
SEC Filings (61)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 4, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Oct 26, 2026 | 8-K | Material event | DocumentIndex |
| Oct 5, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 29, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Apr 16, 2026 | EFFECT | DocumentIndex | |
| Apr 15, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 15, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 15, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 7, 2026 | S-3 | Shelf registration | DocumentIndex |
| Mar 30, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 25, 2026 | EFFECT | DocumentIndex | |
| Mar 25, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 25, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 25, 2026 | 8-K | Material event | DocumentIndex |
| Mar 20, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 13, 2026 | 8-K | Material event | DocumentIndex |
| Feb 6, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Dec 8, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 13, 2025 | S-3 | Shelf registration | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 13, 2025 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 24, 2025 | 8-K/A | Material event | DocumentIndex |
| Oct 6, 2025 | 8-K | Material event | DocumentIndex |
| Sep 19, 2025 | 8-K | Material event | DocumentIndex |
| Sep 19, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 18, 2025 | EFFECT | DocumentIndex | |
| Sep 9, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Sep 9, 2025 | S-3 | Shelf registration | DocumentIndex |